Cargando…

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity

PURPOSE: To study the refractive profile of children after they received intravitreal injection of bevacizumab for retinopathy of prematurity (ROP). METHODS: The study was conducted at a tertiary eye care hospital in South India. ROP patients of more than 1 year of age, presenting to the Pediatric O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawar, Neelam, Somyashree, D, Meenakshi, R, Maheshwari, Devendra, Mohideen, Syed, Uduman, Mohammed Sithiq
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417983/ https://www.ncbi.nlm.nih.gov/pubmed/37322680 http://dx.doi.org/10.4103/ijo.IJO_1209_22

Ejemplares similares

Longitudinal Development of Refractive Error in Children Treated With Intravitreal Bevacizumab or Laser for Retinopathy of Prematurity
por: Simmons, Michael, et al.
Publicado: (2021)

Clinical profile and long term outcomes of eyes with choroidal detachment following trabeculectomy
por: Rao, Sanjana, et al.
Publicado: (2022)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021)

Comparison of the effect of audiovisual and verbal instructions on patient performance while performing automated Humphrey visual field testing
por: Maheshwari, Devendra, et al.
Publicado: (2023)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
por: Minami, Tsuyoshi, et al.
Publicado: (2014)

Evaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration
por: Sahin, Ozlem, et al.
Publicado: (2023)

Non-compliance for wearing spectacles: Prevalence and determinants in school-going children in South India
por: Pawar, Neelam, et al.
Publicado: (2023)

Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age
por: Chen, Yen-Chih, et al.
Publicado: (2018)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Ahmed, Ayesha E., et al.
Publicado: (2010)

Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
por: Chang, Yu-Shan, et al.
Publicado: (2019)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
por: Cevik, Sadik Gorkem, et al.
Publicado: (2020)

Assessment of parental awareness about pediatric visual problems by Knowledge-Attitude-Practice survey in South India
por: Pawar, Neelam, et al.
Publicado: (2023)

Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
por: Abrishami, Majid, et al.
Publicado: (2021)

Inhalation Anesthesia with Sevoflurane during Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity
por: Tokgöz, Orhan, et al.
Publicado: (2013)

Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity
por: Karkhaneh, Reza, et al.
Publicado: (2018)

Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
por: Naravane, Ameay V., et al.
Publicado: (2022)

Impact of glaucoma on vision-specific quality of life in monocular glaucoma patients using the Indian vision function questionnaire
por: Maheshwari, Devendra, et al.
Publicado: (2023)

Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
por: Shoeibi, Nasser, et al.
Publicado: (2018)

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity
por: Kara, Caner, et al.
Publicado: (2017)

Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
por: Bazvand, Fatemeh, et al.
Publicado: (2021)

Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
por: Huang, Ching-Yen, et al.
Publicado: (2022)

Refractive Status of Chinese with Laser-Treated Retinopathy of Prematurity
por: Ruan, Lu, et al.
Publicado: (2015)

Structural and refractive outcomes of intravitreal ranibizumab followed by laser photocoagulation for type 1 retinopathy of prematurity
por: Hoppe, Charis, et al.
Publicado: (2022)

COVID-19 Lockdown: Not a Barrier for Retinopathy of Prematurity Screening
por: Ravindran, Meenakshi, et al.
Publicado: (2022)

Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity
por: Kim, Rebecca, et al.
Publicado: (2014)

Comparison of intravitreal bevacizumab injection and laser photocoagulation for type 1 zone II retinopathy of prematurity
por: Roohipoor, Ramak, et al.
Publicado: (2018)

Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis
por: Higashiyama, Tomoaki, et al.
Publicado: (2017)

Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata, Shumpei, et al.
Publicado: (2019)

Role of deferred retinal laser following intravitreal injection of bevacizumab in treatment of severe retinopathy of prematurity
por: Bhat, Vishalakshi, et al.
Publicado: (2023)

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhy, Srikant, et al.
Publicado: (2018)

Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
por: Lin, Chun-Ju, et al.
Publicado: (2016)

Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity
por: Arima, Mitsuru, et al.
Publicado: (2020)

A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
por: Cheng, Yong, et al.
Publicado: (2018)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Samanta, Ramanuj
Publicado: (2019)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Tripathy, Koushik, et al.
Publicado: (2019)

Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
por: Shrestha, Ruchi, et al.
Publicado: (2019)

COVID-19 myopia, myopia of pandemic: Are we heading towards unpredictable high myopic era?
por: Pawar, Neelam, et al.
Publicado: (2022)

Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query
por: Al Kalbani, Khulood, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t4dcdphq5pksj099kqgoeui5bt